SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-004404
Filing Date
2018-05-09
Accepted
2018-05-09 06:22:01
Documents
57
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tbph-20180331x10q.htm 10-Q 1603232
2 EX-10.1 tbph-20180331ex101811f98.htm EX-10.1 1089171
3 EX-31.1 tbph-20180331ex311e3a807.htm EX-31.1 14940
4 EX-31.2 tbph-20180331ex312135252.htm EX-31.2 14942
5 EX-32 tbph-20180331xex32.htm EX-32 17280
6 GRAPHIC tbph20180331ex101811f98001.jpg GRAPHIC 89572
  Complete submission text file 0001558370-18-004404.txt   6138627

Data Files

Seq Description Document Type Size
7 EX-101.INS tbph-20180331.xml EX-101.INS 909406
8 EX-101.SCH tbph-20180331.xsd EX-101.SCH 39608
9 EX-101.CAL tbph-20180331_cal.xml EX-101.CAL 39945
10 EX-101.DEF tbph-20180331_def.xml EX-101.DEF 115192
11 EX-101.LAB tbph-20180331_lab.xml EX-101.LAB 315219
12 EX-101.PRE tbph-20180331_pre.xml EX-101.PRE 226498
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36033 | Film No.: 18816573
SIC: 2834 Pharmaceutical Preparations